STZ treatment produced a significant decrease in plasma insulin and IL-10 levels and a significant increase in IL-6 and TNF-α levels which suggests an overall increase in inflammatory status in both STZ-induced Type 1 and Type 2 DM mice. This evidence concerns the gene IL10 and diabetes mellitus.